1,2,4-Triazolo-[1,5-<i>a</i>]pyridine HIF Prolylhydroxylase Domain-1 (PHD-1) Inhibitors With a Novel Monodentate Binding Interaction
Saleh A. Ahmed(Umm al-Qura University), Alan G. Hendrick(University of Cambridge), Andrew Ayscough(Takeda (United Kingdom)), Anthony Ivetac(Takeda (United States)), Robert Downham(Takeda (United Kingdom)), Susanne Wright(Takeda (United Kingdom)), Greg R. Barker(Takeda (United Kingdom)), Steven J. Wilkens(Takeda (United States)), Kerry Jenkins, Natalie Webster(Takeda (United Kingdom)), Hannah E. Canning(Takeda (United Kingdom)), Natasha Kinsella(Takeda (United Kingdom)), David Harrison(University of Notre Dame), David G. Livermore(Takeda (United Kingdom)), Richard Davenport(Takeda (United Kingdom)), R.J. Skene(Takeda (United States))
Cited by 34
Related Papers
The <i>GPR54</i> Gene as a Regulator of Puberty
|New England Journal of Medicine|2003|2.5k
Discovery of Clinical Candidate NT-0796, a Brain-Penetrant and Highly Potent NLRP3 Inflammasome Inhibitor for Neuroinflammatory Disorders
|Journal of Medicinal Chemistry|2023|62
Identification of a novel GPR81-selective agonist that suppresses lipolysis in mice without cutaneous flushing
|European Journal of Pharmacology|2014|54
Reversal of High Fat Diet-Induced Obesity, Systemic Inflammation, and Astrogliosis by the NLRP3 Inflammasome Inhibitors NT-0249 and NT-0796
|Journal of Pharmacology and Experimental Therapeutics|2024|51
Myocardial Hypertrophy Resulting from Low Dosage Isoproterenol Administration in Rats
|Experimental Biology and Medicine|1971|49